Rofstad E K, Brustad T, Johannessen J V, Mossige J
Br J Radiol. 1977 May;50(593):314-20. doi: 10.1259/0007-1285-50-593-314.
The effects of 60Co gamma rays and DTIC on two human malignant melanomas, inoculated and passed serially in athymic mutant nude mice, were studied in vivo. Dose-response curves determined after single exposures to 60Co gamma radiation indicate that human malignant melanomas remain radioresistant after transplantation in mutant nude mice. A fractionated irradiation régime, used in the treatment of patients suffering from malignant melanomas, had a considerable effect but did not cure. A corresponding treatment régime with DTIC inhibited the tumour growth, but less effectively than 60Co gamma rays. These two treatments combined were more effective than either alone. The results obtained show no disagreement with results from clinical practice regarding treatment of disseminated malignant melanomas. This suggests that human malignant tissue, transplanted to mutant nude mice, retains its properties with respect to response to therapy. The mutant nude mouse may therefore be valuable in developing new treatment régimes for cancer.
在体内研究了60Coγ射线和达卡巴嗪对在无胸腺突变裸鼠中接种并连续传代的两种人类恶性黑色素瘤的影响。单次暴露于60Coγ辐射后确定的剂量反应曲线表明,人类恶性黑色素瘤在移植到突变裸鼠后仍具有放射抗性。用于治疗恶性黑色素瘤患者的分次照射方案有显著效果,但未能治愈。相应的达卡巴嗪治疗方案抑制了肿瘤生长,但效果不如60Coγ射线。这两种治疗方法联合使用比单独使用更有效。所获得的结果与临床实践中关于播散性恶性黑色素瘤治疗的结果并无分歧。这表明移植到突变裸鼠体内的人类恶性组织在对治疗的反应方面保留了其特性。因此,突变裸鼠在开发新的癌症治疗方案方面可能具有价值。